April 27, 2017 5:25 AM ET

Biotechnology

Company Overview of Ganeden, Inc.

Company Overview

Ganeden, Inc. manufactures and supplies probiotics and probiotic bacteria. The company licenses probiotic technology for use in products in a range of applications, including functional probiotic foods and beverages, probiotic supplements, and topical applications; and feed additives for use in animal health and livestock production. It offers GanedenBacillus coagulans for food, beverage, or companion animal applications; and Bonicel, a probiotic-derived personal care ingredient for anti-aging creams, gels, masks, serums, body lotions, cosmetics, and hair care products. The company’s products are available online and stores across the United States. It has a strategic alliance with Sensus Am...

5800 Landerbrook Drive

Suite 300

Mayfield Heights, OH 44124

United States

Founded in 1997

Phone:

440-229-5200

Fax:

440-229-5240

Key Executives for Ganeden, Inc.

President
Compensation as of Fiscal Year 2016.

Ganeden, Inc. Key Developments

Ganeden Receives Regulatory Approvals for GRAS for Infants

Ganeden continues its trend of being the first to receive regulatory approvals with the announcement that GanedenBC30® (Bacillus coagulans GBI-30, 6086) is FDA GRAS for infant formulas. Already known as the leading probiotic ingredient for functional foods and beverages, GanedenBC30 is now expanding its formulation opportunities into the new space. While the probiotic supplier's previous FDA GRAS certification covered products that could be fed to infants and children, the newest approval allows the strain to be the first and only spore-former to be used specifically in infant formulas. An independent and critical evaluation was performed reviewing the safety of GanedenBC30 relating to usage in infant formulas. The evaluation was conducted by a panel of safety experts, including the Chair of the Department of Pediatrics at Massachusetts General Hospital and Harvard Professor, and overseen by AIBMR. Scientific research on Ganeden's strain was evaluated and the panel unanimously determined that GanedenBC30 is GRAS for use in infant formula. After receiving Self-affirmed GRAS in the Fall of 2016, the international ingredient supplier submitted a notification to the FDA for use in infant formula, which has now received a no objection letter. Probiotics have become increasingly popular in infant products as awareness continues to rise around the importance of boosting beneficial bacteria from the start of life. Babies are born with sterile digestive tracts, and a variety of factors can affect the natural gut flora and the development of their digestive system. GanedenBC30 was the first Bacillus strain to receive GRAS directly from the FDA for adult usage, and has already been formulated into more than 550 probiotic foods and beverages worldwide, including a variety of children's products. The ingredient supplier is now in discussions with leading companies in the infant category to discuss new probiotic developments.

Ganeden Promotes Michael Bush to President

Ganeden has promoted Michael Bush to president of the company. The new president has led the field as both executive board president for the International Probiotics Association and as a speaker and media spokesperson. Promoted from vice president, the new role is intended to allow Bush to concentrate on the company's strategic business development and help manage its growth, both domestically and internationally. He will also continue to manage sales and marketing activities, while maintaining his position as an expert source for media quotes, speaking engagements and educational opportunities. Prior to joining Ganeden, he had more than 20 years of business experience and has won numerous awards for business leadership.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ganeden, Inc., please visit www.ganedenprobiotics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.